Herpes Simplex Virus Type 2 Growth and Latency Reactivation by Cocultivation Are Inhibited with Antisense Oligonucleotides Complementary to the Translation Initiation Site of the Large Subunit of Ribonucleotide Reductase (RR1)
- 1 April 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 10 (2) , 77-85
- https://doi.org/10.1089/oli.1.2000.10.77
Abstract
Antisense oligonucleotides complementary to the translation initiation site of the herpes simplex virus type 2 (HSV-2) large subunit of ribonucleotide reductase (RR1) were studied for their ability to inhibit RR1 expression, HSV-2 growth, and its reactivation from latently infected ganglia. The oligomers caused a significant decrease (90%–97% inhibition) in HSV-2 RR1 expression and inhibited HSV-2 growth, with IC50 and IC90 values of 0.11 and 1.0 μM, respectively. The titers of HSV-2 mutants that are respectively deleted in the PK (ICP10ΔPK) or RR (ICP10ΔRR) domains of RR1 were also significantly (500–20,000-fold) decreased, indicating that the antisense oligomers interfere with the independent contributions of the two RR1 functions (PK and RR) toward virus growth. Inhibition was sequence specific, as evidenced by the failure of a two-base mutant (RRlTImu) to inhibit protein expression and HSV-2 growth. Furthermore, the antisense oligomers inhibited HSV-2 reactivation by cocultivation of latently infected ganglia (0/8). Virus was reactivated from ganglia cultured without oligomers, in the presence of unrelated oligomers (6/8), or in the presence of the two-base mutant RR1TImu (5/8) (p < 0.007 by two-tailed Fisher exact test). HSV-2 growth was not inhibited by antisense oligonucleotides complementary to the splice junction of HSV-2 immediate-early (IE) pre-mRNA 4 and 5 (IE4,5SA) or the translation initiation site of IE mRNA 4 (IE4TI), although the respective HSV-1-specific oligomers inhibit HSV-1 growth.Keywords
This publication has 79 references indexed in Scilit:
- ATP and SH3 Binding Sites in the Protein Kinase of the Large Subunit of Herpes Simplex Virus Type 2 of Ribonucleotide Reductase (ICP10)Published by Elsevier ,1996
- Herpes Simplex Virus-Mediated Activation of Human Immunodeficiency Virus Is Inhibited by Oligonucleoside Methylphosphonates That Target Immediate-Early mRNAs 1 and 3Antisense and Nucleic Acid Drug Development, 1996
- Inhibition of Herpes Simplex Virus Replication by Antisense Oligo-2'-O-methylribonucleoside MethylphosphonatesBiochemistry, 1995
- Quantity of Latency-Associated Transcript Produced by Herpes Simplex Virus Is Not Predictive of the Frequency of Experimental Recurrent Genital HerpesThe Journal of Infectious Diseases, 1994
- A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivoArchiv für die gesamte Virusforschung, 1994
- In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutantVirus Genes, 1993
- The GGTCA palindrome and cognate cellular factors in trans-regulation of human immunodeficiency virus long terminal repeat by herpes simplex virusJournal of General Virology, 1993
- Expression of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for virus growth and neoplastic transformationJournal of General Virology, 1992
- The unique N terminus of the herpes simplex virus type 1 large subunit is not required for ribonucleotide reductase activityJournal of General Virology, 1992
- The Unique N-terminal Domain of the Large Subunit of Herpes Simplex Virus Ribonucleotide Reductase Is Preferentially Sensitive to ProteolysisJournal of General Virology, 1989